✦ LIBER ✦

Concomitant Chemoradiotherapy Using Carboplatin, Tegafur-Uracil and Leucovorin for Stage III and IV Head-and-Neck Cancer: Results of GORTEC Phase II Study

✍ Scribed by Melanie Fesneau; Yoann Pointreau; Sophie Chapet; Laurent Martin; Pascal Pommier; Marc Alfonsi; Brigitte Laguerre; Nasreddine Feham; Christine Berger; Pascal Garaud; Gilles Calais

Book ID: 108148765
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 228 KB
Volume: 76
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2009.01.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concomitant chemoradiotherapy using peme

Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): Preliminary results of a phase II study

✍ Xu, Yaping; Ma, Shenglin; Ji, Yongling; Sun, Xiaojiang; Jiang, Hao; Chen, Jianxi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Phase I–II study: clinical and pharmacok

Phase I–II study: clinical and pharmacokinetic data of docetaxel (DTX), carboplatin (CBDCA) and concomitant radiotherapy (RT) in stage IV head and neck cancer

✍ M. Airoldi; S. Marchionatti; F. Pedani; M. Danova; V. Recalenda; L. Infante; E. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

127 Chemoradiotherapy for stage IV, unme

127 Chemoradiotherapy for stage IV, unmetastatic, head and neck cancer. Preliminary results of a prospective, single-institutional, phase II trial

✍ F. Arias de la Vega; R. Vera; M.A. Dominguez; E. Oria; P. Romero; E. Villafranca 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Carboplatin (CBDCA) and radiotherapy for

Carboplatin (CBDCA) and radiotherapy for stage IV carcinoma of the head and neck: A phase I–II study

✍ Maria C. Jacobs; Mario Eisenberger; Min Chu Oh; Victoria Sinibaldi; William Gray 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 431 KB

Phase I study of concurrent carboplatin

Phase I study of concurrent carboplatin and radiotherapy in previously untreated patients with stage III and IV head and neck cancer

✍ Dr. David Osoba; Dr. Albino D. Flores; Dr. John H. Hay; Dr. Frances Wong; Ms. Ma 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

This study evaluated the toxicity resulting from combined therapy using carboplatin and radiotherapy in 22 patients with locally advanced (stage 111 and IV) head and neck cancer. Carboplatin was given after radiotherapy during the first 5 consecutive days of a 16-fraction course of radiotherapy deli

A phase III study of radiotherapy alone

A phase III study of radiotherapy alone versus radiotherapy plus carboplatin in stage III–IV head and neck cancers. An analysis on oral cavity cancer

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 121 KB